1.Clinical characteristics of vibrio vulnificus infection.
Myung Geun SHIN ; Jong Hee SHIN ; Dong Wook YANG
Korean Journal of Clinical Pathology 1993;13(2):287-293
No abstract available.
Vibrio vulnificus*
;
Vibrio*
2.Evaluation of ATB 32GN system for identification of vibrio vulnificus.
Jong Hee SHIN ; Myung Geun SHIN ; Dong Wook YANG
Korean Journal of Clinical Pathology 1993;13(2):281-286
No abstract available.
Vibrio vulnificus*
;
Vibrio*
3.Production of and sensitivity to bacteriocin, "vulnificin" of vibrio vulnificus.
Journal of the Korean Society for Microbiology 1992;27(3):215-230
No abstract available.
Vibrio vulnificus*
;
Vibrio*
4.Characteristics of protease produced by vibrio vulnificus and its effect on the activity of hemolysin.
Journal of the Korean Society for Microbiology 1992;27(3):207-213
No abstract available.
Vibrio vulnificus*
;
Vibrio*
5.Antimicrobial activity and combination effect of drugs to vibrio vulnificus.
Tai You HA ; Ki Kon OWN ; Hee Sung WHANG ; Jong Wook PARK
Journal of the Korean Society for Microbiology 1991;26(6):519-530
No abstract available.
Vibrio vulnificus*
;
Vibrio*
6.Current Topics on Vibrio vulnificus Infection.
Korean Journal of Clinical Microbiology 1998;1(1):11-13
No abstract available.
Vibrio vulnificus*
;
Vibrio*
7.In vitro ractericidal activity of quinolones against vibrio vulnificus.
Phil Youl RYU ; Jung Inn CHOI ; Joon Haeng RHEE ; Sun Sik CHUNG
Journal of the Korean Society for Microbiology 1992;27(5):449-456
No abstract available.
Quinolones*
;
Vibrio vulnificus*
;
Vibrio*
8.In vitro effect of ciprofloxacin on vibrio vulnificus.
Phil Youl RYU ; Boo Ahn SHIN ; Joon Haeng RHEE ; Sun Sik CHUNG ; Tai Hew AHN
Journal of the Korean Society for Microbiology 1992;27(4):345-357
No abstract available.
Ciprofloxacin*
;
Vibrio vulnificus*
;
Vibrio*
9.Evaluation of repetitive sequence-based genomic fingerprinting for molecular classification and identification of vibrio species.
Gyu Won KIM ; Hun Jong CHUNG ; Chul Min PARK ; Kijeong KIM ; Wonyong KIM ; Sang In CHUNG
Korean Journal of Medicine 2006;71(2):189-197
BACKGROUND: The aims of this study were to compare the suitability of repetitive-PCR genomic fingerprinting procedures to investigate genetic relatedness of the genus Vibrio and its applicability for the molecular identification of Vibrio vulnificus. METHODS: Forty-eight Vibrio strains were included for this study. REP-, ERIC-, BOX- and SERE-PCR were compared with 13 members of the genus Vibrio. RESULTS: REP-, BOX- and SERE-PCR showed V. vulnificus strains could not be separated well from other Vibrio species. However, approximately 320 bp of highly discriminatory specific fragments was recovered from V. vulnificus strains by ERIC-PCR. CONCLUSIONS: ERIC-PCR could be used as rapid classification and identification methods of V. vulnificus from other members of the genus Vibrio.
Classification*
;
Dermatoglyphics*
;
Vibrio vulnificus
;
Vibrio*
10.Cellular Fatty Acid Analysis of Vibrio vulnificus Strains Isolated from Korea.
Jong Hee SHIN ; Dong Wook RYANG ; Myung Geun SHIN ; Soon Pal SUH ; Kyung Sook BAE
Journal of the Korean Society for Microbiology 1997;32(1):27-38
Vibrio vulnificus infection is one of the most fatal diseases in Korea. This study was undertaken to determine the cellular fatty acid (CFA) compositions of ninety-five clinical strains of V. vulnificus isolated from Korea during 1985-1995. We compared these results with the CFA profile of V. vulnificus in the Microbial Identification System (MIS) (CLIN library version 3.9; Microbial ID Inc., Newark, Del.), and also evaluated the MIS ability to identify V. vulnificus. Subgrouping of V. vulnificus by CFA analysis was performed and its results were compared with those of serotyping. Most of the CFAs in V. vulnificus strains were similar to the CFA profile of V. vulnificus in the MIS, but some distinctive differences were observed. First, means of two major CFAs, 16:0 and 16:1w7c, were 22.16% and 18.26% in this study, but 23.52% and 25.44% in the MIS respectively. Second, all isolates had 11:Oiso3OH, which was not present in the MIS. Eighty-five strains (89.5%) disclosed the first choice identification of V. vulnificus by the MIS, but only two strains (2.1%) were identified with SI values of 0.6. Remaining ten strains (10.5%) showed 'NO MATCH' results. Cluster analysis of CFA could separate V. vulnificus into nine subgroups, and predominant subgroups were subgroup VII (45 strains) and V (36 strains). There was heterogeny between subgroups by CFA and serotypes of V. vulnificus. The strains of 04 serotype which accounted for 80% (76/95) of the isolates were distributed into six different subgroups such as VII (40 strains), V (27 strains), III (4 strains), I (2 strains) and VI (1 strain). These showed that V. vulnificus strains isolated from Korea had different characteristics in the CFA composition in comparison with the MIS V. vulnificus library. Subgrouping by the CFA analysis might be a useful tool for the epidemiological study of V. vulnificus infection in Korea.
Korea*
;
Serotyping
;
Vibrio vulnificus*
;
Vibrio*
Result Analysis
Print
Save
E-mail